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A B S T R A C T
Objective: To evaluate the outcome of CIN 2 diagnosed by colposcopy-directed biopsy in women
followed without treatment for 12 months and to verify whether the regression and progression of this
lesion are associated with the woman’s age at diagnosis and age at ﬁrst sexual intercourse.
Study design: Women diagnosed with CIN 2 by biopsy and with previous cervical smear showing LSIL
were included in this cohort study and followed up for one year with cervical smear and colposcopy
every three months. The rates of progression, persistence and regression of the CIN 2 were evaluated.
The Kruskal–Wallis test was used to analyze the woman’s age at diagnosis, age at ﬁrst sexual
intercourse and interval since the ﬁrst sexual intercourse according to the CIN 2 outcome, assuming a
signiﬁcance level of 5%.
Results: At the end of 12months of follow-up the CIN 2 regression ratewas 74% (31/42), progression rate
to CIN 3 was 24% (10/42) and in one case CIN 2 persisted (2%). Among women who had regression, this
event was detected in the ﬁrst six months of follow-up in 26 of the 31 cases. There was no statistically
signiﬁcant association between the evolution of CIN 2 and the woman’s age at diagnosis, age at ﬁrst
sexual intercourse and interval since ﬁrst sexual intercourse. Women whose lesions were restricted to
one quadrant were more likely to have CIN 2 regression at three-month follow-up compared with
women with a lesion extending to one or more quadrants (OR: 6.50; 95% CI: 1.20–35.23).
Conclusions: The results of this study indicate that the majority of CIN 2 diagnosed by biopsy in women
with previous Pap smear showing LSIL will regress in 12 months and therefore an expectant approach
could be considered in these cases, not only for young women. Nevertheless these ﬁndings are not
conclusive, and larger studies are required in order to certify when it is safe to adopt expectant
management for CIN 2.
 2010 Elsevier Ireland Ltd.
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Cervical cancer and its precursor lesion, the cervical intrae-
pithelial neoplasias (CINs) are induced by human papillomavirus
(HPV). It is known that a signiﬁcant percentage of CIN regresses
spontaneously [1]. CIN 2 can show similar behavior to CIN 1 or CIN
3. Evenwhen infected by high risk HPV, if there is predominance of
the productive pattern, CIN 2 evolution would be similar to that of§ Financial support: FAPESP, grant number 2010/07880-8.
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Open access under the Elsevier OA license. CIN 1. In these productive infections, cell proliferation and
episomal maintenance in the lower epithelial layers are followed
by genome ampliﬁcation and the expression of capsid proteins.
Conversely, some CIN 2 lesions and CIN 3 lesions, exhibit a
dramatic topographical change in viral gene expression, which
includes an increase in E6/E7 expression in atypical proliferating
cells [2–4]. Since CIN 2 occurs more frequently in young women
[5], a more conservative approach may be considered, similar to
CIN 1.
In this way, the last consensus of the American Society for
Colposcopy and Cervical Pathology (ASCCP) [6] recommends that
adolescent and young women with CIN 2 conﬁrmed by biopsy and
satisfactory colposcopy can have, rather than immediate treat-
ment, expectant management and follow-up every six months
with colposcopy and a cervical smear for a period of 24months. For
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Fig. 1. Events related to the selection of the women.
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lesion are acceptable treatment [6].
Thus the objective of this study was to evaluate the outcome of
expectantmanagement of CIN 2 diagnosed by colposcopy-directed
biopsy in women followed by cervical smear and colposcopy every
three months for 12months. Considering that the clearance rate of
HPV infection is higher in younger women, and the persistence of
this infection appears to increase with age [7–10], and considering
that the early onset of sexual intercourse is a co-factor of the risk
for cervical cancer [11,12], we decided to evaluate the association
ofwoman’s age at diagnosis and age of ﬁrst sexual intercoursewith
CIN 2 progression and regression rates after 12 months’ follow-up.
2. Materials and methods
2.1. Study design and ethical aspects
A cohort study was carried out between January 2005 and
December 2008 at the Woman´s Hospital Prof Dr Jose Aristodemo
Pinotti-CAISM, State University of Campinas (UNICAMP), Sa˜o
Paulo, Brazil. This study derived from a study previously conducted
in our department to evaluate the management of CIN 1 and was
approved by the Institutional Review Board (IRB) of the Faculty of
Medical Sciences of UNICAMP. For the object of this study, the IRB
of the medical center recommended that the selection criteria
should consider only women with previous low grade squamous
intraepithelial lesion (LSIL), but not high grade squamous
intraepithelial lesion (HSIL). The selection of women followed
strict criteria to ensure that none of them suffered adverse effects
due to CIN 2 treatment delay.
2.2. Selection and follow-up of women
Between January 2005 andDecember 2008, 4732womenwith a
cervical smear showing LSIL, diagnosed according Bethesda
System [13], were invited to participate in this study, through
letters sent together with the reports of the cervical smear. Out of
these women, 1584 agreed to participate and were admitted to the
cervical pathology clinic (Fig. 1). All women had a clinical
evaluation, and underwent to a second cervical smear, a
colposcopic examination and biopsy of suspicious image. The
cervix was divided into four quadrants. The extent of the lesion
was recorded according to the number of involved quadrants on
the cervix and biopsy guided by the worst-appearing.
Women were considered eligible for the study if they fulﬁlled
the following criteria: (1) the second cervical smear showed
atypical squamous cells of undetermined signiﬁcance (ASC-US) or
LSIL; (2) histological diagnosis of CIN 2 [14]; (3) lesion completely
visualized by colposcopy and squamocolumnar junction totally
visible; (4) not pregnant; (5) showing no evidence of any
immunodeﬁciency diseases; (6) no history of previous neoplasms;
and (7) having a ﬁxed address and at least able to provide a ﬁxed
telephone number.
Fiftywomenwho fulﬁlled these criteria agreed toparticipate in
the study and signed the informed consent. These women were
followed during one year with cervical smear and colposcopy
every three months. Women who showed a worsening of the
suspicious image at colposcopy in relation to the previous
examinationwere submitted to biopsy.When the biopsy revealed
CIN 2 or a less severe result, the woman was maintained in the
follow-up plan. When the biopsy revealed CIN 3, immediate
treatment by excision of the lesion was performed. At one year of
follow-up, all the women who still showed cytological or
colposcopy abnormalities were submitted to a complete diagnos-
tic evaluation and were all treated by excision of the lesion for
additional histological analysis.2.3. Outcome of CIN 2 follow-up
The ﬁnal outcome of CIN 2 was classiﬁed as regression,
persistence or progression according to the following criteria:
 Progression: biopsy showing CIN 3 detected at any time during
the follow-up. No lesion worse than CIN 3 was revealed.
 Persistence: biopsy showing CIN 1 or CIN 2 at the twelve-month
follow-up.
 Complete regression: cervical smear, colposcopy and biopsies
without neoplasia observed at any time during the follow-up and
conﬁrmed at the twelve-month follow-up.
At the third, sixth and ninth month follow-up, persistence was
assigned for no changes of the colposcopy image and/or the
cervical smear revealing ASC-US, LSIL or HSIL, speciﬁcally CIN 2
[15]. When the diagnosis of HSIL was classiﬁed as CIN 3, women
underwent colposcopy-directed biopsy. A colposcopy-directed
biopsy which showed CIN 1 and CIN 2 was also assigned as
persistence. The women who showed CIN 3 in the biopsy were
assigned as progression. The analysis included the data collected
according to the follow-up plan. Data about the lesion outcome of
the womenwhomissed the twelve-month follow-up and returned
later on were not included in the analysis. Women who showed
progression to CIN 3 in the intermediate follow-ups were
submitted to excision of the transformation zone (LLETZ) and it
was considered the ﬁnal outcome. The women who showed
regression of the lesion in the intermediate months were followed
up to the twelfth month, to ensure that the lesion actually
regressed at the end of follow-up.
Given that the performance of cervical smears and colposco-
py-directed biopsy may affect the probability of failure in the
diagnosis CIN [16,17], the ideal method for evaluating the
persistence and progression of CIN 2 should be to perform a
LLETZ or cone biopsy, a more accurate diagnostic method.
Table 1
Cumulative frequency of the CIN 2 outcome for every three month follow-up.
3 months 6 months 9 months 12 months
Progression n 1 2 3 10
% 2.6 4.9 7.5 24.0
(95% CI) (0.1–13.5) (0.6–16.5) (1.6–20.4) (12.1–39.5)
Regression n 15 26 28 31
% 38.5 63.4 70.0 74.0
(95% CI) (23.4–55.4) (46.9–77.9) (53.5–83.4) (58.0–86.1)
Persistence n 23 13 9 1
% 59.0 31.7 22.5 2.0
(IC 95%) (42.1–74.4) (18.1–48.1) (10.8–38.5) (0.1–12.6)
Total n 39 41 40 42
Unknowna n 11 9 10 8
CI: conﬁdence interval.
a Includes cases that were discontinued or missed follow-up.
Table 2
Woman’s age at diagnosis, age at ﬁrst sexual intercourse and interval since the ﬁrst sexual intercourse for CIN 2 progression and regression.
Progression Regression p value*
n Average (SD) Median (min–max) n Average (SD) Median (min–max) p* (Kruskall–Wallis)
Age at diagnosis 10 26.7 (8.7) 24.5 (19.0–43.0) 31 27.2 (7.7) 27.0 (17.0–47.0) 0.68
Age at ﬁrst sexual intercourse 8 16.1 (1.9) 16.0 (13.0–18.0) 24 16.6 (2.4) 16.5 (13.0–21.0) 0.61
Interval since the ﬁrst sexual intercourse 8 9.5 (6.2) 7.0 (3.0–22.0) 24 10.3 (7.9) 8.0 (1.0–30.0) 0.96
There was only one case of persistence of CIN 2 conﬁrmed after 12 months, in a woman of 17 years of age.
* Kruskal–Wallis text assuming a signiﬁcance level of 5% (p<0.05).
Table 3
Association between CIN 2 outcome and number of quadrants of the lesion
extension at ﬁrst colposcopic evaluation.
One
quadrant
More than
one quadrant
OR (95% CI)
Outcome n (%) n (%)
3 months follow-up
Regression 13 (52) 02 (14) 6.50 (1.20–35.23)
Persistence or progression 12 (48) 12 (86) Reference
6 months follow-up
Regression 20 (71) 06 (46) 2.92 (0.75–11.41)
Persistence or progression 08 (29) 07 (54) Reference
9 months follow-up
Regression 21(75) 07 (58) 2.14 (0.21–8.97)
Persistence or progression 07 (25) 05 (42) Reference
12 months follow-up
Regression 23 (79) 08 (67) 2.40 (0.46–12.72)
Persistence or progression 06 (21) 05(33) Reference
OR: odds ratio; CI: conﬁdence interval.
The cases that were discontinued or missed the follow-up were not included in the
analysis.
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2.4. Statistical analysis
The rates of progression, regression and persistence of CIN 2,
with a conﬁdence interval of 95%, were calculated for every three-
monthly consultation. The Kruskal–Wallis test was used to analyze
the woman’s age at diagnosis, age at ﬁrst sexual intercourse and
interval since the ﬁrst sexual intercourse, according to the
evolution of the CIN 2, assuming a signiﬁcance level of 5%. The
association between CIN 2 outcome and number of quadrants of
the lesion at ﬁrst colposcopic evaluation was measured by odds
ratio (OR) with 95% conﬁdence intervals (CIs).
3. Results
Eight (16%) of the 50 women followed in this study were not
considered in the ﬁnal evaluation of CIN 2 outcome because they
discontinued their participation due to: diagnosis of persistence in
the previous controls but failure to appear for the ﬁnal consultation
(ﬁve women), diagnosis of HIV conﬁrmed during follow-up (one
woman), three consecutive consultations missed (one woman),
and positive pregnancy test during the ﬁrst control consultation
(one woman). All these eight women received appropriate
management outside the study.
The average age of the 50women included in the studywas 26.5
years and the median was 25 years (min = 17; max = 47). The rates
of progression, regression and persistence of CIN 2 at each follow-
up consultation are shown in Table 1. At the end of the 12 months
of monitoring, there was a 74% rate of regression (31/42), 24% of
progression to CIN 3 (10/42) and only one case of persistence of CIN
2. No case of progression to invasive carcinoma was detected after
12 months of follow-up. Among women who had regression, this
was detected in the ﬁrst six months of follow-up in 26 of the 31
cases.
There was no statistically signiﬁcant association between the
woman’s age at diagnosis, age at ﬁrst sexual intercourse or the
interval since the ﬁrst sexual intercourse, with progression or
regression of CIN 2 at the end of the 12-month period (Table 2).Considering the extent of the initial lesion, one quadrant was
involved in 34% of women and more than one quadrant in 66% of
cases (data not shown). In one case, the colposcopist observed that
the entire lesion has been removed by biopsy, and this casewas not
considered at ﬁnal analysis. Women whose lesions were restricted
to one quadrantweremore likely to have CIN 2 regression at three-
month follow-up when compared with women with a lesion
extending to one ormore quadrants (OR: 6.50; 95% CI: 1.20–35.23)
(Table 3).
4. Comment
According to the results of this study, most CIN 2 regresses
during the ﬁrst six months of follow-up. At the end of 12 months, a
rate of 74% of regression was observed, and 84% of these cases had
regressed by the sixth month of follow-up.
Nasiell et al. [18] followed women with moderate dysplasia
diagnosed in cervical smears and observed a regression rate of 54%
at the end of 78 months. Although our study followed up women
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cervical smear and the second cervical smear showing ASC-US or
LSIL, cytological diagnoses less severe than in the Nasiell study.
Longitudinal studies addressing the natural history of CIN are
based on cytologic, histologic and colposcopic examinations, and
used different nomenclatures and designs [1]. Guedes et al. [19]
monitored women with CIN 2 diagnosed through colposcopy-
directed biopsy in three-monthly follow-up over 12 months. They
observed rates of 42% spontaneous regression. Unlike our study,
Guedes’ study included women with CIN 2 proven biopsy,
regardless of whether the previous cervical smear showed ASCUS,
LSIL or HSIL.
In our study, womenwere selected based on the cervical smear
showing LSIL and the biopsy revealing CIN 2. These criteria might
have selected CIN 2 with characteristics of productive infection,
according to Snijders et al.’s model [2], and this fact could explain
the high rate of regression observed in our study. Castle et al. [20],
analyzing data on an ASCUS/LSIL Triage Study (ALTS) – that is,
women selected based on an ASCUS or LSIL cervical smear – also
considered that CIN 2 detected under these conditions could have
a greater possibility to regress. These authors observed that
women with biopsy-diagnosed CIN 2 following HSIL cytology at
enrollment (women enrolled into ALTS had cytology repeated at
the enrollment visit) were more apt to have an underlying CIN 3
than those with less severe enrollment cytology, and hypothe-
sized that CIN 2 following HSIL cytology may be on average less
regressive than that observed for CIN 2 diagnosed in the ALTS
population.
The rate of progression to CIN 3 was 24%, of which 70% was
detected at the 12-month follow-up. This ﬁnding may be because
all womenwith suspicious colposcopywere subject to LLETZ at the
ﬁnal consultation. In our study, it is possible that some CIN 3 cases
were already present at previous follow-ups but were not detected
in the cytological and colposcopy evaluation, which suggests that
they were borderline lesions to CIN 2. It should also be considered
that the colposcopy-directed biopsy is not 100% sensitive
regarding the detection of more severe lesions present on the
uterine cervix [16]. Thus, it could be that some of the CIN 3 cases
detected in the twelfth month were already present when the
patientwas admitted. The sensitivity of biopsy is greaterwhen two
or more biopsies are carried out [16,17]. In this study only the
location where the image was considered more suspect was
subject to a biopsy, and two locations only when the lesion was
very extensive.
Although the HPV regression rate could be higher in young
women [9,10], in our study the age of the womenwho showed CIN
2 regression was similar to the age of the women with CIN 2
progression. In this context and in agreement with these results,
Rodriguez et al. [9] found that, in womenwith recent infections by
HPV, the rate of progression to CIN 2 or a more severe lesion was
not greater in women of 34 years of age or older. It should be
considered that one sample of 50 cases has a low statistical power
and, therefore, it is not possible to demonstrate statistically an
actual, but discrete, association between age and regression or
progression of CIN 2. On the other hand, if this association was
strong, it would be demonstrated even with a sample of low
statistical power.
The age at ﬁrst sexual intercourse and the interval since ﬁrst
sexual intercourse did not differ for women with regressive or
progressive CIN 2, even though the former is considered to be a co-
factor in the risk of developing CIN and carcinoma of the uterine
cervix [11,12]. Similarly, Moscicki et al. [21], monitoring women
with LSIL, also showed no association between lesion regression
and factors related to sexual behavior.
There is a possibility that biopsymay inﬂuence the regression of
CIN, since it is suggested that biopsy of a small lesion can remove itentirely or precipitate an inﬂammatory response that will be
curative [1,22]. According to the results of this study, a CIN 2 lesion
size no larger than one quadrant presented higher regression rate
at three-month follow-up (OR = 6.5, IC 95%: 1.5–35.2), suggesting
complete disappearance of a small lesion after a diagnostic
procedure at inclusion consultation. These results do not allow
us to assert that CIN 2 involving one quadrant has a higher
regression rate until the third month of follow-up, but we can
afﬁrm that CIN 2 involving one quadrant and undergoing biopsy
has a higher regression rate. Chenoy et al. [22] indicated that
directed punch biopsy trauma does not have a signiﬁcant effect on
the immediate natural history of CIN and did not ﬁnd statistically
signiﬁcant differences in lesion size whether biopsy was employed
or not. Obviously, all CIN 2 must be diagnosed by biopsy; if the
biopsy can induce regression of this lesion; this would be a beneﬁt
for all women.
The results of this study indicate that the majority of CIN 2
diagnosed by biopsy in women with previous Pap smear showing
LSIL will regress in 12 months and, therefore, an expectant
approach could be considered in these cases, not only for young
women as the ASCCP [6] recommends. Nevertheless, these ﬁndings
are not conclusive, but suggest that larger studies are required in
order to certify when it is safe to adopt expectant management for
CIN 2.
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